Stock Evaluator: Marpai, Inc. (MRAI)

Marpai, Inc. MRAI

$2.33 0.35 17.80%
August 21, 2026 3:52:53 PM EST November 10, 2021 Volume: 173,158
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD | DELAYED PRICE
SECTOR INDUSTRY
Financials Insurance

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Marpai, Inc., together with its subsidiaries, operates as a technology-driven healthcare payer company in the United States. The company provides third-party administrator and value-oriented health plan services to employers that directly pay for employee health benefits. It also offers in-house ancillary services that include clinical care management, a nurse-led guide for at-risk members across the care continuum; repricing insights, which are out-of-network claims; Marpai PACCS, a pharmacy advocacy cost containment solution that is a member-driven pharmacy savings program; and MarpaiRx, a national pharmacy benefit management program. In addition, the company provides health plan administration services, third-party vendor services, and complementary services, such as case management, actuarial, and bill review services. It serves the self-insured employer market through healthcare benefits brokers and consultants. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.

Commentary & Analysis


Financial Summary

Share Statistics MRAI Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $62.5 $6,453.5 17%
Shares Out (Mil) 25.9 66.0 34%
Institutional Ownership 8.3% 81.0% 6%
Float (Mil) 13.9 66.5 24%
Beta 4.73 0.52 99%
Avg Daily Volume (000s) 56 218 29%
Price Change
(52-week)
62.3% 89.8% 83%
Growth MRAI Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 5.8% na
Net Income (5yr) (33.6%) 14.3% 12%
EPS (5yr) 31.6% 15.6% 82
Dividends (5yr) na 3.1% 0%
Cash Flow (5yr) (15.0%) (12.2%) 52%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na na na
Current EPS na na na
Month Ago EPS na na na
# Rev Up na na na
# Rev Down na na na
Three Months Ago EPS na na na
Year/Year Chg na na na
Financials MRAI Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $17 $5,268 12%
Net Income (TTM) (Mil) ($17) $562 25%
EPS (TTM) ($0.753) $2.500 24%
Operating Cash Flow (TTM) (Mil) ($9) $632 21%
Net Cash Flow (TTM) (Mil) na $6 na
Long-Term Debt (Q1) (Mil) $25 $917 34%
Enterprise Value (Q1) (Mil) $89 $7,912 21%
Valuation MRAI Industry
Median
Percentile
(All Stocks)
P/B na 1.70 na
P/E na 12.1 na
Dividend Yield 0.0% 1.1% 0%
PEG (5yr hist) na 0.5 na
Ratios MRAI Industry
Median
Percentile
(All Stocks)
Gross Margin 25.9% 34.7% 29%
Net Margin (101.5%) 10.1% 8%
ROA (164.5%) 2.4% 3%
ROE 47.4% 14.6% 92%
Liabilities to Assets 510.8% 77.1% 100%
F-Score 2 6 7%

Marpai, Inc. did not pass any screens on 8/21/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors